Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD
Posted in General

Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD

OpSens said acquisition will provide the company with a global sales channel. A duo of healthtech firms have announced an agreement in which Boston-based…

Continue Reading Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD